Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | -6.38% | -6.88% | -25.11% |
05-09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.11% | 261M | |
+30.38% | 684B | |
+29.69% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.30% | 240B | |
+9.19% | 208B | |
-7.61% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- XERS Stock
- News Xeris Biopharma Holdings, Inc.
- Craig-Hallum Starts Xeris Biopharma Holdings at Buy With $6.50 Price Target